caret icon Back to all discussions

A targeted treatment for emphysema?

That research had found that vascular endothelial growth factor (VEGF), known to be key for blood vessel development, also helps to keep lung tissue healthy, and that VEGF signaling goes awry in emphysema, hastening cell death.

In addition to emphysema, PR1P may have therapeutic potential for acute respiratory distress syndrome (ARDS), a common and devastating disease which also has no cure and is also characterized by abnormalities in VEGF signaling. Adini and Matthews have funding from the Boston Biomedical Innovation Center (B-BIC) to support their ongoing work to develop PR1P as a therapeutic for both emphysema and ARDS.

"We are now also seeing dramatic lung-preserving and anti-inflammatory effects of inhaled PR1P in mice exposed to multiple diverse toxins that induce lung injury in ARDS models," says Adini.

  1. This one sounds interested, great idea Thanks for sharing

    1. Good research, thank you for sharing.

      1. Awesome. Thank you. This is the stuff that gives me hope. I hope it does the same for you.

        A "treatment" that only prolongs this disease does not provide hope. Lung deterioration and comorbities continue.

        Expect more.

        Please read our rules before posting.